Concorde Asset Management, LLC - ANIXA BIOSCIENCES INC ownership

Quarter-by-quarter ownership
Concorde Asset Management, LLC ownership history of ANIXA BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$50,551
+2.0%
15,459
-0.1%
0.05%0.0%
Q2 2023$49,539
-24.8%
15,481
-0.1%
0.05%
-22.0%
Q4 2022$65,875
-16.6%
15,500
-3.0%
0.06%
-33.0%
Q3 2022$79,000
+61.2%
15,975
-0.2%
0.09%
+18.9%
Q2 2022$49,000
+11.4%
16,0000.0%0.07%
+155.2%
Q1 2022$44,000
-8.3%
16,0000.0%0.03%0.0%
Q4 2021$48,000
-22.6%
16,000
+23.1%
0.03%
-19.4%
Q3 2021$62,000
+24.0%
13,0000.0%0.04%
+28.6%
Q2 2021$50,000
-18.0%
13,0000.0%0.03%
-20.0%
Q1 2021$61,00013,0000.04%
Other shareholders
ANIXA BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
MISSION WEALTH MANAGEMENT, LP 501,168$1,638,8200.06%
Concorde Asset Management, LLC 15,459$50,5510.05%
Tyler-Stone Wealth Management 21,008$690.04%
Long Focus Capital Management, LLC 165,701$541,8420.02%
Gemmer Asset Management LLC 35,000$114,4500.02%
Westside Investment Management, Inc. 12,900$42,1830.01%
ADIRONDACK TRUST CO 7,000$22,8200.01%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 14,500$47,1250.01%
NATIONS FINANCIAL GROUP INC, /IA/ /ADV 15,000$49,0500.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 21,000$68,6700.00%
View complete list of ANIXA BIOSCIENCES INC shareholders